Data from animal studies show that IL-18 can lead to pulmonary inflammation [42]; in humans, IL-18 levels increased in patients with idiopathic pulmonary fibrosis [43], patients with ILD-associated inflammatory myopathy [44], and patients with RA-ILD [8]. Here, IL18 is linked to interstitial lung disease.